Biodelivery Sciences International reported $25.47M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 10.5M 37K
Adamas Pharmaceuticals ADMS:US 31.53M 405K
Agile Therapeutics AGRX:US 17.06M 775K
Biocryst Pharmaceuticals BCRX:US $ 85.58M 6.04M
Biodelivery Sciences International BDSI:US $ 25.47M 4.6M
Cara Therapeutics CARA:US $ 21.4M 9.48M
Cti Biopharma CTIC:US $ 23.38M 3.88M
Daiichi Sankyo 4568:JP 226.92B 8.62B
Depomed DEPO:US $ 19.54M 17.84M
Endo International Ordinary Shares ENDP:US $ 682.87M 112.15M
JAZZ PHA JAZZ:US $ 809.75M 11.66M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Knight Therapeutics Inc GUD:CN C$ 69.23M 3.63M
Lannett LCI:US $ 109.67M 30.16M
Mannkind MNKD:US $ 23.87M 31.81M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Pacira Pharmaceuticals PCRX:US $ 96.29M 4.46M
Pfizer PFE:US $ 16447M 3384M
Redhill Biopharma RDHL:US 39.01M 7.38M
Revance Therapeutics RVNC:US $ 92.47M 3.33M
Teva Pharmaceutical TEVA:IT 3.26B 64M